Hermann Lübbert
Chief Executive Officer chez BIOFRONTERA INC.
Fortune : 8 749 $ au 29/02/2024
Profil
Hermann Lübbert founded Biofrontera AG.
Currently, he is Chairman & Chief Executive Officer of Biofrontera, Inc. and Co-Managing Director at Biofrontera Bioscience GmbH.
He is also Professor at Ruhr-Universität Bochum.
In the past he occupied the position of Chairman-Management Board & CEO at Biofrontera AG, Co-Managing Director at Biofrontera Pharma GmbH and Member of Novartis Pharma AG.
He received a doctorate from Universität zu Köln.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
BIOFRONTERA, INC.
0,21% | 03/11/2023 | 10 440 ( 0,21% ) | 8 749 $ | 29/02/2024 |
Postes actifs de Hermann Lübbert
Sociétés | Poste | Début |
---|---|---|
BIOFRONTERA INC. | Chief Executive Officer | 26/05/2023 |
Ruhr-Universität Bochum | Corporate Officer/Principal | - |
Biofrontera Bioscience GmbH
Biofrontera Bioscience GmbH Financial ConglomeratesFinance Part of Biofrontera AG, Biofrontera Bioscience GmbH is a German commercial biotech company that provides high-quality treatment options in photodynamic therapy and topical antibiotics. The private company is based in Leverkusen, Germany. The CEOs of the company are Thomas Schaffer, Hermann Lübbert. | Chief Executive Officer | - |
Anciens postes connus de Hermann Lübbert
Sociétés | Poste | Fin |
---|---|---|
BIOFRONTERA AG | Chief Executive Officer | 13/12/2021 |
Biofrontera Pharma GmbH
Biofrontera Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Part of Infinity Pharmaceuticals, Inc., Biofrontera Pharma GmbH is a German company that provides natural products drug discovery services. The private company is based in Leverkusen, Germany. The CEOs are Hermann Lübbert, Thomas Schaffer, Christoph Dünwald. The company was founded in 2003. Biofrontera Pharma was acquired by Discovery Partners International, Inc. from Biofrontera AG on June 30, 2005. | Chief Executive Officer | - |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Formation de Hermann Lübbert
Universität zu Köln | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
BIOFRONTERA AG | Health Technology |
BIOFRONTERA INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Biofrontera Pharma GmbH
Biofrontera Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Part of Infinity Pharmaceuticals, Inc., Biofrontera Pharma GmbH is a German company that provides natural products drug discovery services. The private company is based in Leverkusen, Germany. The CEOs are Hermann Lübbert, Thomas Schaffer, Christoph Dünwald. The company was founded in 2003. Biofrontera Pharma was acquired by Discovery Partners International, Inc. from Biofrontera AG on June 30, 2005. | Commercial Services |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Biofrontera Bioscience GmbH
Biofrontera Bioscience GmbH Financial ConglomeratesFinance Part of Biofrontera AG, Biofrontera Bioscience GmbH is a German commercial biotech company that provides high-quality treatment options in photodynamic therapy and topical antibiotics. The private company is based in Leverkusen, Germany. The CEOs of the company are Thomas Schaffer, Hermann Lübbert. | Finance |